email article
Citing "numerous" reports of infections associated with reprocessed urological endoscopes, the FDA wants providers to pay extra attention to careful cleaning and inspection following use of these devices.
In a "Dear Health Care Provider" letter dated Thursday, the FDA said it is "currently investigating the potential causes and contributing factors associated with the reported infections and contamination issues."
"While some reports indicate possible inadequate reprocessing or maintenance issues (for example, device failed leak testing) as a potential cause, the FDA is also evaluating other potential issues including reprocessing instructions in the labeling and device design," the letter added.